We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
Cap. Flow
+$77.2M
Cap. Flow %
0.8%
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$53.4M
2
OXY icon
Occidental Petroleum
OXY
+$38M
3
COF icon
Capital One
COF
+$36.7M
4
ELV icon
Elevance Health
ELV
+$27.1M
5
KR icon
Kroger
KR
+$20.2M

Top Sells

Rank Stock Value
1
ALGN icon
Align Technology
ALGN
+$43.2M
2
MSFT icon
Microsoft
MSFT
+$36.6M
3
QCOM icon
Qualcomm
QCOM
+$34.8M
4
MA icon
Mastercard
MA
+$33.6M
5
MRK icon
Merck
MRK
+$33.4M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Healthcare 14.84%
3 Consumer Discretionary 14.57%
4 Financials 13.21%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MG icon
1076
Mistras Group
MG
$477M
-38,879
Closed -$154K
MGNI icon
1077
Magnite
MGNI
$2.83B
-85,972
Closed -$573K
MSBI icon
1078
Midland States Bancorp
MSBI
$697M
-16,367
Closed -$245K
MUR icon
1079
Murphy Oil
MUR
$5.55B
-10,606
Closed -$146K
MXL icon
1080
MaxLinear
MXL
$5.19B
-104,985
Closed -$2.25M
NOG icon
1081
Northern Oil and Gas
NOG
$2.29B
-12,122
Closed -$102K
NOV icon
1082
NOV
NOV
$6.84B
-14,717
Closed -$180K
NTLA icon
1083
Intellia Therapeutics
NTLA
$1.51B
-16,764
Closed -$352K
NWBI icon
1084
Northwest Bancshares
NWBI
$2.33B
-12,375
Closed -$127K
NWN icon
1085
Northwest Natural Holdings
NWN
$2.15B
-8,113
Closed -$453K
NWPX icon
1086
NWPX Infrastructure Inc
NWPX
$1.19B
-8,358
Closed -$210K
OBK icon
1087
Origin Bancorp
OBK
$1.7B
-9,136
Closed -$201K
PACB icon
1088
Pacific Biosciences
PACB
$435M
-193,469
Closed -$667K
PAYX icon
1089
Paychex
PAYX
$43.4B
-3,162
Closed -$240K
PDFS icon
1090
PDF Solutions
PDFS
$1.72B
-52,194
Closed -$1.02M
PFS icon
1091
Provident Financial Services
PFS
$3.14B
-27,324
Closed -$395K
PGRE
1092
DELISTED
Paramount Group
PGRE
-23,173
Closed -$179K
PRK icon
1093
Park National Corp
PRK
$3.84B
-17,440
Closed -$1.23M
PSNL icon
1094
Personalis
PSNL
$1.25B
-14,748
Closed -$191K
PTGX icon
1095
Protagonist Therapeutics
PTGX
$8.55B
-68,279
Closed -$1.21M
RF icon
1096
Regions Financial
RF
$26.4B
-19,320
Closed -$215K
RRGB icon
1097
Red Robin
RRGB
$139M
-13,055
Closed -$133K
SEE
1098
DELISTED
Sealed Air
SEE
-91,273
Closed -$3M
SIG icon
1099
Signet Jewelers
SIG
$3.84B
-162,600
Closed -$1.67M
SPFI icon
1100
South Plains Financial
SPFI
$850M
-13,419
Closed -$191K

Similar funds

Jacobs Levy Equity Management's Q3 2020 Portfolio in Review

As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
  • Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
  • Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
  • Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
  • Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
  • Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
  • Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.